A porcine-brain-derived enzymatic hydrolysate (CAS 12656-61-0) consisting of a mixture of low-molecular-weight (<10 kDa) neuropeptides and free amino acids. Manufactured by EVER Neuro Pharma (Austria); intended to mimic endogenous neurotrophic factor activity (BDNF, GDNF, NGF). Approved in over 40 countries — including Austria, Russia, China, and much of Eastern Europe and Asia — for stroke, traumatic brain injury, and dementia. Not FDA-approved.
For research purposes only. Not medical advice.
Ruo Bio currently lists Cerebrolysin at $0.10/mg, the lowest indexed price across 2 tracked research peptide vendors.
Cerebrolysin ranges from $0.10/mg to $1.11/mg across 2 listings from 2 research peptide vendors, normalized to USD per milligram and refreshed daily.
2 research peptide vendors currently list Cerebrolysin on PeptideScouter. We track 2 active listings across size and kit variants.
Cerebrolysin's CAS Registry Number is 12656-61-0. It is also sold as Cerebroprotein Hydrolysate.